Christy Tangney to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Christy Tangney has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.561
-
Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia. Clin Sci (Lond). 2004 Feb; 106(2):215-7.
Score: 0.210
-
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998 May 27; 279(20):1643-50.
Score: 0.142
-
Short-term reduction in bone markers with high-dose simvastatin. Osteoporos Int. 2005 Oct; 16(10):1272-6.
Score: 0.058
-
Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects. J Lab Clin Med. 2005 Feb; 145(2):83-7.
Score: 0.056
-
Comparative study of HMG-CoA reductase inhibitors on fibrinogen. Atherosclerosis. 2001 Apr; 155(2):463-6.
Score: 0.043
-
Inhibition of proinflammatory cytokine production by pravastatin. Lancet. 1999 Mar 20; 353(9157):983-4.
Score: 0.037
-
Elevated soluble tumor necrosis factor receptor levels in non-obese adults with the atherogenic dyslipoproteinemia. Atherosclerosis. 2004 Nov; 177(1):77-81.
Score: 0.014